197 related articles for article (PubMed ID: 16546485)
1. Effect of inhibition of alpha-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats.
Yamamoto M; Otsuki M
Metabolism; 2006 Apr; 55(4):533-40. PubMed ID: 16546485
[TBL] [Abstract][Full Text] [Related]
2. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
[TBL] [Abstract][Full Text] [Related]
3. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats.
Yamashita K; Sugawara S; Sakairi I
Horm Metab Res; 1984 Apr; 16(4):179-82. PubMed ID: 6373545
[TBL] [Abstract][Full Text] [Related]
4. Acarbose feeding increases pancreatic islet blood flow in obese glucose-intolerant Otsuka Long-Evans Tokushima fatty rats.
Iwase M; Imoto H; Oku M; Shibata S; Sonoki K; Iida M
Pancreas; 2008 Aug; 37(2):228-30. PubMed ID: 18665092
[No Abstract] [Full Text] [Related]
5. Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models.
Kong WH; Oh SH; Ahn YR; Kim KW; Kim JH; Seo SW
J Agric Food Chem; 2008 Apr; 56(8):2613-9. PubMed ID: 18363357
[TBL] [Abstract][Full Text] [Related]
6. Acarbose, an alpha-glucosidase inhibitor, improves insulin resistance in fructose-fed rats.
Nakamura K; Yamagishi S; Matsui T; Inoue H
Drugs Exp Clin Res; 2005; 31(4):155-9. PubMed ID: 16223205
[TBL] [Abstract][Full Text] [Related]
7. Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus.
Dimitriadis G; Karaiskos C; Raptis S
Horm Metab Res; 1986 Apr; 18(4):253-5. PubMed ID: 3519413
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between structural and functional changes of islets, and abnormal metabolism of glucose and lipids in OLETF rats with impaired glucose tolerance].
Liu Y; Xu Z; Zhang J
Zhonghua Yi Xue Za Zhi; 2000 Mar; 80(3):175-7. PubMed ID: 11798752
[TBL] [Abstract][Full Text] [Related]
9. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
10. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Nakagawa T; Goto H; Hussein G; Hikiami H; Shibahara N; Shimada Y
Diabetes Res Clin Pract; 2008 Apr; 80(1):40-7. PubMed ID: 18242756
[TBL] [Abstract][Full Text] [Related]
11. Effects of the alpha-glucosidase inhibitor acarbose on postprandial serum glucose and insulin concentrations in healthy dogs.
Robertson J; Nelson R; Kass P; Neal L
Am J Vet Res; 1999 May; 60(5):541-5. PubMed ID: 10328421
[TBL] [Abstract][Full Text] [Related]
12. Taurine alters respiratory gas exchange and nutrient metabolism in type 2 diabetic rats.
Harada N; Ninomiya C; Osako Y; Morishima M; Mawatari K; Takahashi A; Nakaya Y
Obes Res; 2004 Jul; 12(7):1077-84. PubMed ID: 15292471
[TBL] [Abstract][Full Text] [Related]
13. Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats.
Kirino Y; Sato Y; Kamimoto T; Kawazoe K; Minakuchi K
Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E372-9. PubMed ID: 21139073
[TBL] [Abstract][Full Text] [Related]
14. Effect of lowering postprandial hyperglycemia on insulin secretion in older people with impaired glucose tolerance.
Chang AM; Smith MJ; Bloem CJ; Galecki AT; Halter JB
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E906-11. PubMed ID: 15213063
[TBL] [Abstract][Full Text] [Related]
15. The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance.
Chiasson JL
Diabet Med; 1996; 13(3 Suppl 2):S23-4. PubMed ID: 8689858
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
[TBL] [Abstract][Full Text] [Related]
17. Postprandial serum lipids and tissue lipoprotein lipase are acutely altered in rats by the alpha-glucosidase inhibitor acarbose.
Picard F; Deshaies Y
Horm Metab Res; 1996 Aug; 28(8):377-80. PubMed ID: 8886823
[TBL] [Abstract][Full Text] [Related]
18. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
Jia D; Yamamoto M; Otani M; Otsuki M
Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
[TBL] [Abstract][Full Text] [Related]
20. The effect of probucol on the development of non-insulin dependent diabetes mellitus in Otsuka Long Evans Tokushima Fatty (OLETF) rats.
Ishida K; Shi K; Mizuno A; Sano T; Shima K
Tokushima J Exp Med; 1994 Jun; 41(1-2):41-7. PubMed ID: 7940531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
